Bupivacaine TTS not checked

Durect

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Contains bupivacaine base, in a flexible and rectangular-shaped, transdermal, delivery system. Three patches applied to the lower back every 72 hours for 12 weeks.”In the company’s words, NCT01096966 on ClinicalTrials.gov
Tested for
Chronic Low Back Pain
Main trialPhase 2
“This study will evaluate the efficacy and safety of Bupivacaine TTS (Bupivacaine patch) compared to placebo in patients with chronic low back pain.”In the company’s words, NCT01096966 on ClinicalTrials.gov

Other drugs for Chronic Low Back Pain

All 48 drugs for Chronic Low Back Pain

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed Feb 2011 Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Bupivacaine TTS

Following is part of Solo: you see every change to Bupivacaine TTS the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in